The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer

MLA

Angelo Delmonte, et al. “The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer.” Frontiers in Oncology, vol. 11, May 2021. EBSCOhost, https://doi.org/10.3389/fonc.2021.669839.

APA

Angelo Delmonte, Giuseppe Bronte, Sara Bravaccini, Maria Maddalena Tumedei, Marco Angelo Burgio, Maurizio Puccetti, Lorenza Landi, Paola Cravero, Paola Ulivi, Lucio Crinò, Elisabetta Petracci, Sara Ravaioli, Federico Cappuzzo, & Simona Scodes. (2021). The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer. Frontiers in Oncology, 11. https://doi.org/10.3389/fonc.2021.669839

Chicago

Angelo Delmonte, Giuseppe Bronte, Sara Bravaccini, Maria Maddalena Tumedei, Marco Angelo Burgio, Maurizio Puccetti, Lorenza Landi, et al. 2021. “The Interplay Between Programmed Death Ligand 1 and Vimentin in Advanced Non-Small-Cell Lung Cancer.” Frontiers in Oncology 11 (May). doi:10.3389/fonc.2021.669839.